BG103106A - Trovafloxacin mesilate tablets - Google Patents

Trovafloxacin mesilate tablets

Info

Publication number: BG103106A
Authority: BG; Bulgaria
Prior art keywords: tablets; trovafloxacin mesilate; mesilate; trovafloxacin; compositions
Prior art date: 1998-01-21

Application number

BG103106A

Other languages

Bulgarian (bg)

English (en)

Inventor

Alton JOHNSON

Christopher SINKO

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-21

Filing date

1999-01-21

Publication date

1999-08-31

1999-01-21 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

1999-08-31 Publication of BG103106A publication Critical patent/BG103106A/xx

Links

229960000497 trovafloxacin Drugs 0.000 title abstract 2
WVPSKSLAZQPAKQ-CDMJZVDBSA-N trovafloxacin Chemical compound C([C@H]1[C@@H]([C@H]1C1)N)N1C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=NC=1N2C1=CC=C(F)C=C1F WVPSKSLAZQPAKQ-CDMJZVDBSA-N 0.000 title abstract 2
229920000168 Microcrystalline cellulose Polymers 0.000 abstract 3
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 3
239000008108 microcrystalline cellulose Substances 0.000 abstract 3
229940016286 microcrystalline cellulose Drugs 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
238000004090 dissolution Methods 0.000 abstract 1
239000000314 lubricant Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BG103106A 1998-01-21 1999-01-21 Trovafloxacin mesilate tablets BG103106A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US7201398P	1998-01-21	1998-01-21

Publications (1)

Publication Number	Publication Date
BG103106A true BG103106A (en)	1999-08-31

Family

ID=22105016

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG103106A BG103106A (en)	1998-01-21	1999-01-21	Trovafloxacin mesilate tablets

Country Status (34)

Country	Link
US (1)	US6187341B1 (fr)
EP (1)	EP0930068A3 (fr)
JP (1)	JPH11269072A (fr)
KR (1)	KR100314977B1 (fr)
CN (1)	CN1227743A (fr)
AP (1)	AP1094A (fr)
AR (1)	AR012780A1 (fr)
AU (1)	AU758381B2 (fr)
BG (1)	BG103106A (fr)
BR (1)	BR9900116A (fr)
CA (1)	CA2259698C (fr)
CO (1)	CO4810225A1 (fr)
DZ (1)	DZ2712A1 (fr)
EA (1)	EA003247B1 (fr)
GT (1)	GT199900004A (fr)
HR (1)	HRP990023A2 (fr)
HU (1)	HUP9900154A3 (fr)
ID (1)	ID23735A (fr)
IL (1)	IL128051A0 (fr)
IS (1)	IS4947A (fr)
MA (1)	MA24747A1 (fr)
NO (1)	NO990243L (fr)
NZ (1)	NZ333838A (fr)
OA (1)	OA10958A (fr)
PA (1)	PA8466701A1 (fr)
PE (1)	PE20000169A1 (fr)
PL (1)	PL330981A1 (fr)
SG (1)	SG70666A1 (fr)
SK (1)	SK4299A3 (fr)
TN (1)	TNSN99007A1 (fr)
TR (1)	TR199900089A3 (fr)
TW (1)	TW518224B (fr)
YU (1)	YU2399A (fr)
ZA (1)	ZA99393B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9915208A (pt) *	1998-11-10	2001-07-31	Bayer Ag	Preparado farmacêutico de moxifloxacina
AU1188601A (en) *	1999-09-20	2001-04-24	Alza Corporation	Process for lessening polymorphic conversion of a drug
ECSP003699A (es) *	1999-10-08	2002-04-23	Smithkline Beecham Corp	Inhibidores de fab i
FR2808441B1 (fr) *	2000-05-04	2004-06-18	Oreal	Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) *	2000-06-26	2002-02-14	Bayer Ag	Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
DE60230934D1 (de) *	2001-04-06	2009-03-05	Affinium Pharm Inc	Fab-i-inhibitoren
EP1396263A1 (fr) *	2002-08-09	2004-03-10	Warner-Lambert Company	Compositions d'enrobage pour tablettes et caplets
EP1575951B1 (fr)	2002-12-06	2014-06-25	Debiopharm International SA	Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
CN100415284C (zh) *	2002-12-30	2008-09-03	毛友昌	六味木香片的制备方法
WO2004082586A2 (fr)	2003-03-17	2004-09-30	Affinium Pharmaceuticals, Inc.	Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
EP1459739B1 (fr) *	2003-03-19	2008-01-02	The Jordanian Pharmaceutical Manufacturing Co. Ltd.	Compositions pharmaceutiques non-hygroscopique contenant des acides carboxiliques quinilones non-hydratés
US8906413B2 (en) *	2003-05-12	2014-12-09	Supernus Pharmaceuticals, Inc.	Drug formulations having reduced abuse potential
WO2005009395A2 (fr) *	2003-07-23	2005-02-03	L. Perrigo Company	Composition contenant des fibres cellulosiques
US8450307B2 (en)	2004-06-04	2013-05-28	Affinium Pharmaceuticals, Inc.	Therapeutic agents, and methods of making and using the same
WO2006044805A2 (fr) *	2004-10-15	2006-04-27	Supernus Pharmaceuticals, Inc.	Preparations pharmaceutiques pour lesquelles le risque d'abus est reduit
CA2632476A1 (fr) *	2005-12-05	2007-06-14	Affinium Pharmaceuticals, Inc.	Agents therapeutiques et ses procedes de fabrication et d'utilisation
EP2687533B1 (fr)	2006-07-20	2017-07-19	Debiopharm International SA	Dérivés d'acrylamide en tant qu'inhibiteurs de FAB I
WO2008098374A1 (fr) *	2007-02-16	2008-08-21	Affinium Pharmaceuticals, Inc.	Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
KR101720885B1 (ko)	2012-06-19	2017-03-28	데비오팜 인터네셔날 에스 에이	(e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
RS61312B1 (sr)	2016-02-26	2021-02-26	Debiopharm Int Sa	Lek za lečenje infekcija dijabetskog stopala
MY203711A (en)	2019-02-14	2024-07-15	Debiopharm Int Sa	Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja)	2019-06-14	2024-01-19	デバイオファームインターナショナルエス．エー．	バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用
EP4580618A2 (fr) *	2022-08-30	2025-07-09	Pannex Therapeutics Inc.	Modulateurs de pannexine-1 et procédés de traitement de troubles dans lesquels la pannexine-1 est impliquée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3601566A1 (de) *	1986-01-21	1987-07-23	Bayer Ag	Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en)	1986-01-21	1994-02-15	Bayer Aktiengesellschaft	Pharmaceutical formulations of ciprofloxacin
US4957554A (en)	1989-08-16	1990-09-18	Minnesota Mining And Manufacturing Company	Dimensionally-controlled ceramics
DE4120646A1 (de)	1991-06-22	1992-12-24	Bayer Ag	7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
PL325170A1 (en) *	1995-08-29	1998-07-06	Pfizer	Bipolar forms of throwaflocacin

1999
- 1999-01-11 PA PA19998466701A patent/PA8466701A1/es unknown
- 1999-01-13 EP EP99300258A patent/EP0930068A3/fr not_active Withdrawn
- 1999-01-14 TR TR1999/00089A patent/TR199900089A3/tr unknown
- 1999-01-14 SK SK42-99A patent/SK4299A3/sk unknown
- 1999-01-14 IL IL12805199A patent/IL128051A0/xx unknown
- 1999-01-14 AP APAP/P/1999/001443A patent/AP1094A/en active
- 1999-01-15 PE PE1999000036A patent/PE20000169A1/es not_active Application Discontinuation
- 1999-01-15 ID IDP990036D patent/ID23735A/id unknown
- 1999-01-15 OA OA9900009A patent/OA10958A/en unknown
- 1999-01-15 GT GT199900004A patent/GT199900004A/es unknown
- 1999-01-15 MA MA25433A patent/MA24747A1/fr unknown
- 1999-01-19 IS IS4947A patent/IS4947A/is unknown
- 1999-01-19 JP JP11010298A patent/JPH11269072A/ja active Pending
- 1999-01-19 AR ARP990100191A patent/AR012780A1/es not_active Application Discontinuation
- 1999-01-19 CA CA002259698A patent/CA2259698C/fr not_active Expired - Fee Related
- 1999-01-19 BR BR9900116-0A patent/BR9900116A/pt not_active IP Right Cessation
- 1999-01-20 NO NO990243A patent/NO990243L/no not_active Application Discontinuation
- 1999-01-20 NZ NZ333838A patent/NZ333838A/xx unknown
- 1999-01-20 DZ DZ990013A patent/DZ2712A1/fr active
- 1999-01-20 KR KR1019990001589A patent/KR100314977B1/ko not_active Expired - Fee Related
- 1999-01-20 US US09/233,823 patent/US6187341B1/en not_active Expired - Fee Related
- 1999-01-20 CN CN99101232A patent/CN1227743A/zh active Pending
- 1999-01-20 ZA ZA9900393A patent/ZA99393B/xx unknown
- 1999-01-20 YU YU2399A patent/YU2399A/sh unknown
- 1999-01-20 SG SG1999000117A patent/SG70666A1/en unknown
- 1999-01-20 AU AU12173/99A patent/AU758381B2/en not_active Ceased
- 1999-01-20 PL PL99330981A patent/PL330981A1/xx unknown
- 1999-01-20 TN TNTNSN99007A patent/TNSN99007A1/fr unknown
- 1999-01-20 HU HU9900154A patent/HUP9900154A3/hu unknown
- 1999-01-21 TW TW088100897A patent/TW518224B/zh not_active IP Right Cessation
- 1999-01-21 CO CO99003190A patent/CO4810225A1/es unknown
- 1999-01-21 EA EA199900046A patent/EA003247B1/ru not_active IP Right Cessation
- 1999-01-21 BG BG103106A patent/BG103106A/xx unknown
- 1999-01-21 HR HR60/072,013A patent/HRP990023A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0930068A3 (fr)	1999-12-22
TNSN99007A1 (fr)	2005-11-10
CN1227743A (zh)	1999-09-08
HRP990023A2 (en)	1999-08-31
DZ2712A1 (fr)	2003-09-01
HUP9900154A2 (hu)	1999-09-28
EP0930068A2 (fr)	1999-07-21
NO990243L (no)	1999-07-22
KR19990068014A (ko)	1999-08-25
KR100314977B1 (ko)	2001-11-24
SK4299A3 (en)	2000-06-12
EA199900046A2 (ru)	1999-08-26
CO4810225A1 (es)	1999-06-30
AR012780A1 (es)	2000-11-08
AP9901443A0 (en)	1999-03-31
SG70666A1 (en)	2000-02-22
AU1217399A (en)	1999-08-12
US6187341B1 (en)	2001-02-13
BR9900116A (pt)	2000-05-02
NZ333838A (en)	2000-03-27
EA199900046A3 (ru)	1999-12-29
CA2259698A1 (fr)	1999-07-21
TR199900089A2 (xx)	1999-10-21
GT199900004A (es)	2000-07-08
PE20000169A1 (es)	2000-03-10
NO990243D0 (no)	1999-01-20
JPH11269072A (ja)	1999-10-05
PL330981A1 (en)	1999-08-02
HUP9900154A3 (en)	2000-12-28
TW518224B (en)	2003-01-21
ZA99393B (en)	2000-07-21
AP1094A (en)	2002-08-19
MA24747A1 (fr)	1999-10-01
EA003247B1 (ru)	2003-02-27
IS4947A (is)	1999-07-22
ID23735A (id)	2000-05-11
OA10958A (en)	2001-10-31
AU758381B2 (en)	2003-03-20
IL128051A0 (en)	1999-11-30
HU9900154D0 (en)	1999-03-29
PA8466701A1 (es)	2000-09-29
CA2259698C (fr)	2003-04-15
TR199900089A3 (tr)	1999-10-21
YU2399A (sh)	2002-06-19

Publication	Publication Date	Title
BG103106A (en)	1999-08-31	Trovafloxacin mesilate tablets
TR200103186T2 (tr)	2002-04-22	MEK enzimlerinin inhibitörleri olarak kinolin türevleri
BG103413A (en)	2000-02-29	Derivatives of sulphinic acid, their production and application
HK1039110A1 (zh)	2002-04-12	以新颖的合成物及组分作为蛋白酶抑制剂
AU2002220715A1 (en)	2002-06-03	Indolsulfonyl compounds useful in the treatment of cns disorders
GEP20033000B (en)	2003-06-25	2-Substituted-1-Piperidyl Benzimidazole Compounds as ORL1-Receptor Agonists
AP2002002458A0 (en)	2002-06-30	Compounds for the treatment of ischemia.
DE3474631D1 (en)	1988-11-24	N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
BG106013A (en)	2002-05-31	New compounds and compositions as protease inhibitors
AU6011301A (en)	2001-09-24	1,2,3,4-tetrahydroisoquinoline derivatives
IS7545A (is)	2004-11-22	7-Arýl-3,9-díasabísýkló(3.3.1)nón-6-en afleiður og notkun þeirra sem renín hindra í meðferð á háþrýstingi, hjarta- og æða- eða nýrna sjúkdómum
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
AU2003269327A1 (en)	2004-05-04	Tetrahydroquinoline derivatives as crth2 antagonists
IL114599A0 (en)	1995-11-27	Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
FI970147A0 (fi)	1997-01-14	Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
CA2390649A1 (fr)	2001-05-17	Composes de 5-aryl-1h-1,2,4-triazole en tant qu'inhibiteurs de cyclooxygenase-2 et compositions pharmaceutiques les contenant
CA2378428A1 (fr)	2001-02-15	Utilisation d'antagonistes de cgrp et d'inhibiteurs de secretion cgrp servant a lutter contre les bouffees de chaleur de la menopause
BG106239A (en)	2002-08-30	Improved pharmaceutical formulations
AU5915100A (en)	2001-01-30	Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
AU2003295866A1 (en)	2004-06-18	Effervescent compositions
CA2378834A1 (fr)	2001-01-25	Pyrazinones, compositions contenant ces composes
PT1427417E (pt)	2008-06-02	Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
MY120550A (en)	2005-11-30	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
MXPA02004441A (es)	2004-09-10	Derivados de isoxazol como inhibidores de la fosfodiesterasa.
BG102661A (en)	1999-04-30	Benzo/o/quinolysine derivatives, their preparation and application as 5a-reductase inhibitors